Patent Infringement is conducted in order to determine whether a product or a process infringes upon an existing patent claim.  Whenever a product is set to be launched in a specific market, an Infringement analysis is advised to mitigate the risks of infringement of patents in that particular territory. The report cites similar patents existing in the territory and evaluates the risks of infringement, if any, in launching a particular product. Pharmaceutical and biotechnology patents are at an extremely high risk of infringement. At Ligamine, we have a service specifically for this sector which consists of tracking of and following-up on any patent or data protection infringement at the local health authorities and patent offices to ensure proper protection.